Clinical Trial Design & Biostatistical Analysis Support

The contract requires expert consultation to support the design and statistical analysis of clinical trials focused on Parkinson’s disease, with specific emphasis on methodology including randomization and blinding techniques to ensure scientific rigor and regulatory compliance. The contractor will be responsible for developing a comprehensive statistical analysis plan that aligns with industry standards and supports the integrity of human subject research, ensuring data validity and interpretability throughout the trial lifecycle. This work is critical to advancing therapeutic evaluations under tightly controlled conditions appropriate for neurodegenerative disease studies. The engagement is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under NAICS code 541940 for other scientific and technical consulting services. The opportunity was posted on June 18, 2026, with a_response deadline of November 6, 2026, indicating a five-month window for proposal submission. Although no specific location or point of contact is provided, the performance location remains undetermined, and the contract is not subject to any set-aside provisions. The scope demands high-level expertise in biostatistics and clinical trial infrastructure tailored to Parkinson’s disease research environments.